Home › NDC Lookup › Ingredients › Aspirin › 70677-1122-01
⚪image loading
(from DailyMed)

Enteric Coated Aspirin 325 mg Tablet, Delayed Release, 125-count

by STRATEGIC SOURCING SERVICES LLC · 1 BOTTLE, PLASTIC in 1 CARTON (70677-1122-1) / 125 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC
NDC 70677-1122-01
🏷️ FDA NDC (as labeled) 70677-1122-1 billing pads the package segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 70677-1122-1
Product NDC 70677-1122
11-digit billing NDC 70677112201
NCPDP billing unit EA — each (per item)
RxCUI 198467
UNII R16CO5Y76E
UPC 0010939957733
Application # M013
SPL Set ID 32cc6e05-84c1-4710-bebc-cb6e7133dc54
Established class (EPC) Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor
Mechanism of action Cyclooxygenase Inhibitors
Physiologic effect Decreased Prostaglandin Production; Decreased Platelet Aggregation
Chemical class Anti-Inflammatory Agents, Non-Steroidal
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-09-05
Route ORAL
Dosage form TABLET, DELAYED RELEASE
Substance ASPIRIN
GPI-14 64100010000605
GCN Seq No 004381
GCN 16720
HICL code 001820
Ingredient (HICL) Aspirin
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H3
Therapeutic class — intermediate (HIC2) Analgesics
HIC3 code H3D
Therapeutic class — specific (HIC3) Analgesic/Antipyretics, Salicylates
AHFS code 20:12.18.00
AHFS class Platelet-Aggregation Inhibitors
FDB label name FT ASPIRIN EC 325 MG TABLET
FDB brand name Aspirin Ec
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 70677-1122-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1122-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Platelet Aggregation Inhibitor class.

Pharmacologic class Platelet Aggregation Inhibitor, Nonsteroidal Anti-inflammatory Drug
Drug family (ATC) Other agents for local oral treatment, Platelet aggregation inhibitors excl. heparin, Salicylic acid and derivatives
How it works Cyclooxygenase Inhibitors
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerSTRATEGIC SOURCING SERVICES LLC
FDA applicationM013 (OTC MONOGRAPH DRUG)
Labeler code70677
First marketedSep 2023
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name FT ASPIRIN EC 325 MG TABLET Ingredient Aspirin
📖 What it is MedlinePlus · NLM

Aspirin is used to: reduce fever relieve mild to moderate pain and inflammation prevent heart attacks, strokes or mini-strokes reduce the risk of death in people who are experiencing or who have had a heart attack Aspirin is in a group of medications called salicylates. It works by blocking natural substances that cause fever, pain, swelling, and blood clots. Aspirin is also available in combination with other medications such as pain relievers and cough and cold medications. This monograph only includes information about the use of aspirin alone. If you are taking a combination product,...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Aspirin is used to temporarily relieve common minor pains — things like headaches, backaches, muscle aches, toothaches, menstrual cramps, and discomfort from a cold — and to reduce...
  • Generally, no — aspirin should not be given to children under 12. More importantly, children and teenagers who have or are recovering from chickenpox or a flu-like illness should n...
  • Yes, stomach upset, heartburn, and nausea are real possibilities with aspirin. Taking it with a full glass of water helps. Some people tolerate enteric-coated or delayed-release fo...
  • Does aspirin upset your stomach? What can I do about it?
📖 Read our full Aspirin guide →
3
Nutrient depletion considerations

Aspirin may be associated with lower levels of 3 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Aspirin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII LMI26O6933
    Alumina is a white powder form of aluminum oxide. It's used as a filler to add bulk to tablets and capsules, and sometimes as a thickening or anti-caking agent in powdered formulations.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII 35SW5USQ3G
    A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
  • UNII 92RU3N3Y1O
    Dimethicone is a silicone-based oil that acts as an anti-foaming agent and lubricant in medicines. It reduces gas bubbles in liquid formulations and helps coat and protect the stomach lining when ingested.
  • UNII H77VEI93A8
    A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 74G4R6TH13
    A synthetic polymer made by combining two plastic-like chemicals. It forms a coating on tablets or capsules that dissolves at a specific point in the digestive tract, controlling where and when the medicine releases.
  • UNII T5L8T28FGP
    Mineral oil is a clear, odorless liquid derived from crude oil. It acts as a lubricant and emollient in medications, helping pills slide smoothly during manufacturing and aiding moisture retention in topical products.
  • UNII 6OZP39ZG8H
    Polysorbate 80 is a synthetic emulsifier derived from sorbitol and oleic acid. It helps mix oil and water-based ingredients together in medications and improves how the product disperses in the body.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 368GB5141J
    A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII 8Z96QXD6UM
    Triethyl citrate is a clear liquid derived from citric acid. It acts as a plasticizer and solvent in tablet coatings and film formulations, helping the coating remain flexible and adhere properly to the medicine.

16 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescorn starch, croscarmellose sodium, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake, hypromellose, methacrylic acid copolymer, microcrystalline cellulose, mineral oil, polysorbate 80, simethicone, sodium hydroxide, sodium lauryl sulfate, talc, titanium dioxide, triethyl citrate

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.022 $2.76 / 125 tablets
Medicaid paysCMS SDUD · 12 mo $0.3251 $40.64 / 125 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2024 Jan 2026 Apr 2026 Aug 2026 $0.023 $0.022
▼ Down 4% over the last 11 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Enteric Aspirin 325 mg 63868-0898-10 CHAIN 100 tablets $0.019 — FDA listed save 15%
Aspirin Regular Strength 325 mg 00536-1232-01 Rugby 100 tablets $0.022 — Availability likely —
Aspirin 325 mg 46122-0596-02 Amerisource 125 tablets $0.022 — Availability likely —
Regular Strength Aspirin 325 mg 70000-0014-01 CARDINAL 300 tablets $0.022 — Availability likely —
Aspirin Regular Strength 325 mg 70000-0035-01 Cardinal 125 tablets $0.022 — Availability likely —
Enteric Coated Aspirin 325 mgthis 70677-1122-01 STRATEGIC 125 tablets $0.022 — Availability likely —
Enteric Aspirin 325 mg 83324-0058-01 Chain 100 tablets $0.022 — Availability likely —
Bayer Aspirin Regimen enteric coated 325 mg 00280-2110-10 Bayer 100 tablets — — FDA listed —
Aspirin Enteric Coated, Regular Strength 325 mg 00363-0227-14 Walgreen 500 tablets — — FDA listed —
Aspirin 325 325 mg 00363-0691-12 Walgreen 100 tablets — — FDA listed —
Aspirin 325 mg 00363-6453-53 WALGREENS 500 tablets — — FDA listed —
aspirin pain relief 325 mg 11822-2270-04 Rite 500 tablets — — FDA listed —
Aspirin Regular Strength 325 mg 11822-6910-01 Rite 100 tablets — — FDA listed —
Aspirin 325 mg 17714-0011-01 Advance 100 tablets — — FDA listed —
Regular Strength Enteric coated aspirin 325 mg 17856-0922-01 ATLANTIC 1 tablet — — FDA listed —
Enteric Coated Aspirin Regular Strength 325 mg 21130-0081-05 Safeway 500 tablets — — FDA listed —
Aspirin 325 mg 37808-0174-32 H-E-B 300 tablets — — FDA listed —
Aspirin Regular Strength 325 mg 41163-0522-02 United 125 tablets — — FDA listed —
Enteric Coated Aspirin Regular Strength 325 mg/3251 49483-0331-00 Time-Cap 100000 tablets — — FDA listed —
Aspirin 325 mg 51662-1494-01 HF 100 tablets — — FDA listed —
Enteric Coated Aspirin 325 mg 53943-0081-02 DISCOUNT 125 tablets — — FDA listed —
Aspirin 325 mg 54738-0111-01 Richmond 100 tablets — — FDA listed —
Regular Strength Enteric coated aspirin 325 mg 57896-0921-01 Geri-Care 100 tablets — — FDA listed —
Aspirin 325 mg 59779-0157-14 CVS 500 tablets — — FDA listed —
Regular Strength Enteric coated aspirin 325 mg 60760-0799-24 St. 24 tablets — — FDA listed —
Ecotrin Regular Strength 325 mg 63029-0302-01 Medtech 300 tablets — — FDA listed —
Enteric Coated Aspirin 325 mg 63941-0181-02 VALU 125 tablets — — FDA listed —
Aspirin 325 mg 67091-0110-10 WinCo 100 tablets — — Discontinued —
Aspirin 325 mg 68071-5192-01 NuCare 100 tablets — — FDA listed —
Aspirin 325 Mg Ec 69618-0015-01 Reliable 100 tablets — — FDA listed —
Aspirin 325 mg 69842-0927-14 CVS 500 tablets — — FDA listed —
Aspirin 325 Mg Ec 71205-0318-20 Proficient 20 tablets — — FDA listed —
Enteric Coated Aspirin Regular Strength 325 mg 71335-0157-01 Bryant 30 tablets — — FDA listed —
Regular Strength Enteric coated aspirin 325 mg 71335-0513-01 Bryant 30 tablets — — FDA listed —
Aspirin 325 Mg Ec 71335-1800-01 Bryant 30 tablets — — FDA listed —
Aspirin 325 mg 71610-0034-65 Aphena 100 tablets — — FDA listed —
Aspirin 325 mg 72036-0181-02 HARRIS 125 tablets — — FDA listed —
Aspirin 325 mg 72789-0556-07 PD-Rx 7 tablets — — FDA listed —
Aspirin Enteric Coated, Regular Strength 325 mg 77333-0035-20 Gendose 1 tablet — — FDA listed —
Aspirin 325 mg 79481-2270-05 Meijer 125 tablets — — FDA listed —
Aspirin 325 mg 80425-0293-01 Advanced 30 tablets — — FDA listed —
Aspirin 325 mg 81522-0018-11 FSA 100 tablets — — FDA listed —
Aspirin 325 mg 84269-2501-01 Wildman 2 tablets — — FDA listed —
Aspirin 325 mg 85111-0921-10 RMT 1000 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2023
On the market since
Sep 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 70677-1122-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
1.7K
Units reimbursed last 4 qtrs
65.3K
Gross reimbursed last 4 qtrs
$21.2K
Avg / prescription
$12.23
Avg / unit
$0.3251
Latest quarter Q4 2025
470Rx
Medicaid pays / ea
$0.3251
gross reimbursed
vs
NADAC / ea
$0.0221
acquisition cost
=
Spread
+$0.3030
+1371% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
72% FFS 28% MCO
Fee-for-service · 1,246 Rx Managed care · 489 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 4,264 units · 54.6 per 100k residents WA Idaho: no data reported ID Montana: 520 units · 45.9 per 100k residents MT North Dakota: no data reported ND Minnesota: 3,945 units · 68.8 per 100k residents MN Wisconsin: 7,686 units · 130 per 100k residents WI Michigan: 4,932 units · 49.1 per 100k residents MI New York: 8,474 units · 43.3 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 1,555 units · 48.5 per 100k residents IA Illinois: no data reported IL Indiana: 732 units · 10.7 per 100k residents IN Ohio: 824 units · 7.0 per 100k residents OH Pennsylvania: 1,380 units · 10.6 per 100k residents PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 15,354 units · 39.4 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 5,735 units · 290 per 100k residents NE Missouri: 3,751 units · 60.5 per 100k residents MO Kentucky: 2,486 units · 54.9 per 100k residents KY West Virginia: 2,214 units · 125 per 100k residents WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: 1,413 units · 39.1 per 100k residents CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
7.0290
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Nebraska 290 /100k
2 Wisconsin 130 /100k
3 West Virginia 125 /100k
4 Minnesota 68.8 /100k
5 Missouri 60.5 /100k
6 Kentucky 54.9 /100k
7 Washington 54.6 /100k
8 Michigan 49.1 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Enteric Coated Aspirin (this brand).

Top reported reactions

Fatigue31,729
Dyspnoea27,102
Nausea26,290
Diarrhoea26,244
Dizziness22,241
Headache19,446
Asthenia18,649

Age at onset

Neonate871
Infant273
Child646
Adolescent306
Adult28,256
Elderly50,201

Reporter sex

508,138 reports
Male · 51%
Female · 49%
Unknown · 0%

Serious outcomes

Hospitalization199,412
Death46,448
Life-threatening24,696
Disabling15,131
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 34,733 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
70677-1122-01 You're viewing this 1 BOTTLE, PLASTIC in 1 CARTON (70677-1122-1) / 125 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC 2023-09-05 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 29 words ▾

Uses for the temporary relief of minor aches and pains due to: headache muscle pain toothache menstrual pain colds minor pain of arthritis or as recommended by your doctor

⏱️ Dosage and Administration 50 words ▾

Directions drink a full glass of water with each dose adults and children 12 years and over: take 1 to 2 tablets every 4 hours while symptoms last; do not take more than 12 tablets in 24 hours unless directed by a doctor children under 12 years: ask a doctor

⚠️ Warnings ~2 min read ▾

Warnings Reye's syndrome Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness. Allergy alert Aspirin may cause a severe allergic reaction which may include: hives facial swelling asthma (wheezing) shock Stomach bleeding warning This product contains an NSAID, which may cause severe stomach bleeding.

The chance is higher if you: are age 60 or older have had stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others) have 3 more alcoholic drinks every day while using this product take more or for a longer time than directed Do not use if you are allergic to aspirin or any other pain reliever/fever reducer Ask a doctor before use if stomach bleeding warning applies to you you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, or kidney disease you are taking a diuretic you have asthma Ask a doctor or pharmacist before use if you are taking a prescription drug for: diabetes gout arthritis Stop use and ask a doctor if an allergic reaction occurs.

Seek medical help right away. you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better pain gets worse or lasts for more than 10 days redness or swelling is present fever gets worse or lasts for more than 3 days new symptoms occur ringing in the ears or loss of hearing occurs These could be signs of a serious condition If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📦 Storage and Handling 18 words ▾

Other information store between 20-25°C (68-77°F) in a dry place retain carton for complete product information and warnings

🧪 Active Ingredient 13 words ▾

Active ingredient (in each tablet) Aspirin 325 mg (NSAID)* * nonsteroidal anti-inflammatory drug

🧪 Inactive Ingredients 37 words ▾

Inactive ingredients corn starch, croscarmellose sodium, D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake, hypromellose, methacrylic acid copolymer, microcrystalline cellulose, mineral oil, polysorbate 80, simethicone, sodium hydroxide, sodium lauryl sulfate, talc, titanium dioxide, triethyl citrate

🎯 Purpose 3 words ▾

Purpose Pain reliever

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 70677-1121-01 · STRATEGIC 70677-1123-01 · STRATEGIC →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.